Cargando…

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review

Radiomics and artificial intelligence (AI) may increase the differentiation of benign from malignant kidney lesions, differentiation of angiomyolipoma (AML) from renal cell carcinoma (RCC), differentiation of oncocytoma from RCC, differentiation of different subtypes of RCC, to predict Fuhrman grade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferro, Matteo, Crocetto, Felice, Barone, Biagio, del Giudice, Francesco, Maggi, Martina, Lucarelli, Giuseppe, Busetto, Gian Maria, Autorino, Riccardo, Marchioni, Michele, Cantiello, Francesco, Crocerossa, Fabio, Luzzago, Stefano, Piccinelli, Mattia, Mistretta, Francesco Alessandro, Tozzi, Marco, Schips, Luigi, Falagario, Ugo Giovanni, Veccia, Alessandro, Vartolomei, Mihai Dorin, Musi, Gennaro, de Cobelli, Ottavio, Montanari, Emanuele, Tătaru, Octavian Sabin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126666/ https://www.ncbi.nlm.nih.gov/pubmed/37113657 http://dx.doi.org/10.1177/17562872231164803

Ejemplares similares

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement
por: Ferro, Matteo, et al.
Publicado: (2023)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy
por: Ferro, Matteo, et al.
Publicado: (2022)

Beyond PSA: The Role of Prostate Health Index (phi)
por: Ferro, Matteo, et al.
Publicado: (2020)

Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies
por: Ferro, Matteo, et al.
Publicado: (2020)

Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared
por: Mistretta, Francesco A., et al.
Publicado: (2020)

Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis
por: Ferro, Matteo, et al.
Publicado: (2021)

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Robot-assisted inguinal lymphadenectomy: preliminary experience and perioperative outcomes from an Italian referral center
por: Cozzi, Gabriele, et al.
Publicado: (2020)

A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients
por: Mistretta, Francesco A., et al.
Publicado: (2020)

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Outcomes of robot-assisted simple enucleation of renal masses: A single European center experience
por: Matei, Deliu Victor, et al.
Publicado: (2017)

Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
por: Ferro, Matteo, et al.
Publicado: (2021)

Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active Surveillance
por: Ferro, Matteo, et al.
Publicado: (2021)

Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes
por: Musi, Gennaro, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

The impact the COVID-19 pandemic on urology literature: a bibliometric analysis
por: Crocerossa, Fabio, et al.
Publicado: (2022)

Robot-Assisted Intracorporeal Orthotopic Ileal Neobladder: Description of the “Shell” Technique
por: Bianchi, Roberto, et al.
Publicado: (2021)

Neuraxial anesthesia versus general anesthesia in patients undergoing three-dimensional laparoscopic radical prostatectomy: Preliminary results of a prospective comparative study
por: Alba, Stefano, et al.
Publicado: (2023)

Quality of Life and Psychological Distress among Patients with Small Renal Masses
por: Vartolomei, Liliana, et al.
Publicado: (2022)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
por: Ferro, Matteo, et al.
Publicado: (2021)

Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2018)

Long-Term Follow-Up Outcomes after Percutaneous US/CT-Guided Radiofrequency Ablation for cT1a-b Renal Masses: Experience from Single High-Volume Referral Center
por: Mauri, Giovanni, et al.
Publicado: (2020)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub
por: Luzzago, Stefano, et al.
Publicado: (2021)

Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors
por: Balan, Daniel, et al.
Publicado: (2018)

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
por: Ferro, Matteo, et al.
Publicado: (2016)

Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score
por: Musi, Gennaro, et al.
Publicado: (2023)

Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center
por: Annese, Pasquale, et al.
Publicado: (2021)

A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor
por: Mistretta, Francesco A, et al.
Publicado: (2022)

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Publication trend for COVID-19 in Urology: What have Urologists researched in a year and a half of the Pandemic?
por: Crocerossa, F., et al.
Publicado: (2022)

Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches
por: Mistretta, Francesco Alessandro, et al.
Publicado: (2019)

Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer
por: Ferro, Matteo, et al.
Publicado: (2021)

Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies
por: Marvaso, Giulia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bot6012r4lh8prjucg778dv2oh